Old Web
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
53
References
58
Citations
NaN
KQI